Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Contract Research Organization Market

Contract Research Organization Market Size

  • Report ID: GMI3012
  • Published Date: Mar 2023
  • Report Format: PDF

Contract Research Organization Market Size

Contract Research Organization Market size accounted for USD 56.7 billion in 2022 and is estimated to grow at 6.9% CAGR between 2023 and 2032. Rising adoption of advanced technologies for efficient R&D outcomes and the increasing outsourcing trends in the clinical trials industry has largely influenced the global market growth.

 

The significant shift from maintaining manual/paper-based records to digital data capture technologies is largely transforming and propelling the market growth. Moreover, the advent of COVID-19 has largely triggered the adoption of digital resources across clinical trials enhancing the quality of data while allowing greater flexibility. Furthermore, digital technologies can transform the companies’ approach towards clinical development by incorporating valuable insights from multiple sources and increasing the volume of data collected in trials enhancing clinical trial productivity, thereby fuelling the market expansion

 

Contract research organization, also known as clinical research organization, is a company that assists in managing complex clinical research & trial responsibilities, clinical development & commercialization of new products for sponsor companies and drug discovery primarily in the biotechnology, medical device and pharmaceutical industries. These organizations offer services such as clinical trial management, preclinical research, clinical research, commercialization, and pharmacovigilance among other research services. These are outsourced on contract basis, also known as fee-for-service basis.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for contract research organization stood at over USD 56.5 billion in 2022 and is predicted to exhibit more than 6.5% CAGR from 2023 to 2032 due to a significant rise in R&D investments worldwide.

Clinical research service segment is anticipated to garner over USD 63.5 billion by 2032, attributed to the increasing incidences of chronic health conditions and the escalating new drug delivery projects.

Academic institute segment is expected to witness over 5% CAGR from 2023 to 2032 owing to the escalating clinical research activities across academic institutes.

Prominent operating in the CRO market include Charles River Laboratories, Inc., CMIC HOLDING Co., Ltd, Clinipace Inc., EPS International Co., Ltd (EPS Group), IQVIA, Laboratory Corporation of America Holdings (Covance Inc), ICON plc, Medpace, Inc, and PAREXEL International, among others.

Contract Research Organization Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 22
  • Tables & Figures: 406
  • Countries covered: 14
  • Pages: 287
 Download Free Sample